earnings
saveREGENERON PHARMACEUTICALS, INC. earnings
community read0 votes
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
view source ↗Data sources
Found something off?
same company · ±60 days · 4
- phase 2 completioncemiplimab: Regeneron Pharmaceuticals Inc — cemiplimab (Phase II Trial Completion)Apr 30, 2026
- pdufadupilumab: Regeneron Pharmaceuticals Inc — dupilumab (PDUFA)Apr 27, 2026
- approvaldupilumab: DUPIXENT (DUPILUMAB) — FDA approvalApr 16, 2026
- approvalEYLEA HD: EYLEA HD (AFLIBERCEPT) — FDA approvalApr 2, 2026
related news · 3
- oncliveCases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
- statSTAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more
- biopharma diveFDA approves Regeneron’s hearing loss gene therapy
comments(0)
5-min edit window · permanent after that